Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Gut and Liver
>
2017
>
11
>
1
Volume:
11
Issue:
1
1. Reply: The Characteristics about Our Study in Irritable Bowel Syndrome.
Page:168—168
2. Colored Ring-Shaped Thread Tag Clippings to Identify the Accurate Location of Multiple Polyps Resected via Endoscopic Mucosal Resection.
Page:164—165
3. Protection Provided by a Gabexate Mesylate Thermo-Sensitive In Situ Gel for Rats with Grade III Pancreatic Trauma.
Page:156—163
4. Feasibility of Endoscopic Papillary Large Balloon Dilation in Patients with Difficult Bile Duct Stones without Dilatation of the Lower Part of the Extrahepatic Bile Duct.
Page:149—155
5. Antireflux Metal Stent as a First-Line Metal Stent for Distal Malignant Biliary Obstruction: A Pilot Study.
Page:142—148
6. Persistent α-Fetoprotein Elevation in Healthy Adults and Mutational Analysis of α-Fetoprotein Promoter, Enhancer, and Silencer Regions.
Page:136—141
7. Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study.
Page:129—135
8. Generation of Multilayered 3D Structures of HepG2 Cells Using a Bio-printing Technique.
Page:121—128
9. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma.
Page:112—120
10. Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition.
Page:102—111
11. Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis.
Page:93—101
12. Quality of Life after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Prospective Multicenter Cohort Study.
Page:87—92
13. Helicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis.
Page:79—86
14. Critical Appraisal of “Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study”.
Page:166—167
15. Underestimation of Smoking Rates in an East Asian Population with Crohn's Disease.
Page:73—78
16. Effectiveness of Capsule Endoscopy Compared with Other Diagnostic Modalities in Patients with Small Bowel Crohn’s Disease: A Meta-Analysis.
Page:62—72
17. Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease.
Page:55—61
18. Factors That Affect Stent-Related Complications in Patients with Malignant Obstruction of the Esophagus or Gastric Cardia.
Page:47—54
19. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.
Page:38—46
20. 25 Years of Proton Pump Inhibitors: A Comprehensive Review.
Page:27—37
21. Cholangiocarcinoma: Current Knowledge and New Developments.
Page:13—26
22. The Potential Role of Elk-3/Egr-1 Signaling Pathway in the Epithelial-Mesenchymal Transition during Liver Fibrosis.
Page:11—12
23. Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for Cirrhosis.
Page:9—10
24. Role of Smoking as a Risk Factor in East Asian Patients with Crohn's Disease.
Page:7—8
25. Is Effective of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Small Bowel Crohn’s Disease?.
Page:5—6
26. Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?.
Page:3—4
27. Investigation of Factors Affecting Clinical Outcomes after Stent Placement in Malignant Obstruction of the Esophagus or the Gastric Cardia.
Page:1—2